Case Study: Novartis accelerates time-to-IND with Genedata Vico

A Genedata Case Study

Preview of the Novartis Case Study

Novartis accelerates IND timelines with Genedata

Novartis, a leading global biopharmaceutical company, faced the challenge of managing vast and complex Chemistry, Manufacturing, and Controls (CMC) data generated by cross-functional teams. This data, produced from various analytical technologies without harmonization, made it difficult to extract insights for timely decision-making. To address this, Novartis partnered with vendor Genedata to implement its Genedata Vico solution.

By implementing Genedata Vico, Novartis was able to harmonize multi-source CMC data and convert it into governed, analysis-ready data products. This solution enabled seamless integration across experiments and technologies and supported downstream analytics, including AI/ML. As a result, Genedata helped Novartis accelerate its time-to-IND (Investigational New Drug) timelines, allowing teams to act faster and with greater clarity across the entire CMC lifecycle.


View this case study…

Genedata

23 Case Studies